Randomized controlled trials comparing nutrient supplements to standard diets or placebos in COPD patients will be analyzed up to August 31, 2024.
COPD patients suffering from or face higher healthcare costs and poorer clinical outcomes.
The effectiveness of nutrient supplements in improving health outcomes for these patients is currently uncertain.
A comprehensive review will assess the efficacy of nutrient supplements based on a wide range of studies.
Tools for evaluating study quality, including the modified Jadad scale and Cochrane Collaboration's risk of bias tool, will be utilized.
Potential limitations include uncertain study quality and small sample sizes in some trials, which may affect evidence credibility.
Simplified
BACKGROUND: COPD patients suffering from or often incur higher healthcare costs and experience adverse clinical outcomes. Despite this, the effectiveness of nutrient supplements in this population remains uncertain.
METHODS AND ANALYSIS: Two reviewers will independently search seven databases-PubMed, Embase, Web of Science, China National Knowledge Infrastructure, Wanfang, Chinese Biomedical Literature Database, and the Cochrane Library-for randomized controlled trials (RCTs) published before August 31, 2024. These RCTs should compare the effects of nutrient supplements against either a standard diet or placebo supplements in patients with COPD. The risk of bias in the included studies will be evaluated using the modified Jadad scale and the Cochrane Collaboration's risk of bias tool. Data synthesis will be conducted using RevMan software. Trial sequential analysis (TSA) will be applied to the primary outcomes. Additionally, subgroup and sensitivity analyses will be performed to assess the robustness of the findings.
ETHICS AND DISSEMINATION: Ethical approval is not required because this study is a secondary analysis of existing data. We will disseminate the findings through peer- reviewed publications.
SYSTEMATIC REVIEW REGISTRATION: CRD42024585694.
STRENGTHS AND LIMITATIONS OF THIS STUDY: This systematic review and meta-analysis provides a thorough assessment of the efficacy of nutrient supplements in COPD patients, covering a wide range of studies. ·The use of the modified Jadad scale and the Cochrane Collaboration's risk of bias tool ensures a robust evaluation of study quality. Additionally, trial sequential analysis and subgroup analyses are employed to enhance the robustness of the findings. ·The credibility of the evidence may be compromised due to the potential for uncertain study quality and limited sample sizes in some included trials.
Key numbers
approximately 50%
Prevalence of in COPD patients
This figure reflects the proportion of COPD patients affected by , highlighting the need for targeted nutritional strategies.
CRD42024585694
Registration ID for the study protocol
This ID corresponds to the protocol registered in the PROSPERO database, indicating the systematic review's planned methodology.
Full Text
We can’t show the full text here under this license.
Declarations. Ethics approval and consent to participate: Not applicable, as this study is a systematic review and meta-analysis of existing published data. Consent for publication: Not applicable. Competing interests: The authors declare that they have no competing financial interests or personal relationships that may have influenced the work reported in this study.
